Susquehanna International Group
WST icon

Susquehanna International Group’s West Pharmaceutical WST Stock Holding History

Susquehanna International Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6M Buy
94,300
+25,100
+36% +$6.25M ﹤0.01% 2019
2025
Q4 		$19M Sell
69,200
-13,900
-17% -$3.8M ﹤0.01% 2269
2025
Q3 		$21.8M Sell
83,100
-45,500
-35% -$11.1M ﹤0.01% 2112
2025
Q2 		$28.1M Sell
128,600
-38,600
-23% -$8.25M ﹤0.01% 1664
2025
Q1 		$37.4M Buy
167,200
+33,500
+25% +$9.23M 0.01% 1210
2024
Q4 		$43.8M Buy
133,700
+89,000
+199% +$28M 0.01% 1224
2024
Q3 		$13.4M Sell
44,700
-19,500
-30% -$5.97M ﹤0.01% 2248
2024
Q2 		$21.1M Sell
64,200
-16,700
-21% -$5.9M ﹤0.01% 1663
2024
Q1 		$32M Buy
80,900
+46,600
+136% +$17.2M 0.01% 1353
2023
Q4 		$12.1M Sell
34,300
-20,800
-38% -$7.36M ﹤0.01% 2399
2023
Q3 		$20.7M Sell
55,100
-52,900
-49% -$20.5M ﹤0.01% 1707
2023
Q2 		$41.3M Buy
108,000
+12,200
+13% +$4.36M 0.01% 1127
2023
Q1 		$33.2M Buy
95,800
+56,200
+142% +$16.4M 0.01% 1241
2022
Q4 		$9.32M Sell
39,600
-24,500
-38% -$5.81M ﹤0.01% 2358
2022
Q3 		$15.8M Buy
64,100
+5,900
+10% +$1.8M ﹤0.01% 1646
2022
Q2 		$17.6M Sell
58,200
-20,000
-26% -$6.51M ﹤0.01% 1564
2022
Q1 		$32.1M Buy
78,200
+36,500
+88% +$14.3M 0.01% 1298
2021
Q4 		$19.6M Buy
41,700
+17,400
+72% +$7.49M ﹤0.01% 1873
2021
Q3 		$10.3M Buy
24,300
+4,600
+23% +$1.94M ﹤0.01% 2817
2021
Q2 		$7.07M Sell
19,700
-11,500
-37% -$3.8M ﹤0.01% 3411
2021
Q1 		$8.79M Buy
31,200
+5,600
+22% +$1.6M ﹤0.01% 2977
2020
Q4 		$7.25M Buy
25,600
+11,000
+75% +$3.09M ﹤0.01% 2900
2020
Q3 		$4.01M Sell
14,600
-14,100
-49% -$3.73M ﹤0.01% 3360
2020
Q2 		$6.52M Buy
28,700
+9,200
+47% +$1.81M ﹤0.01% 2660
2020
Q1 		$2.97M Buy
19,500
+7,300
+60% +$1.12M ﹤0.01% 3301
2019
Q4 		$1.83M Buy
12,200
+1,800
+17% +$262K ﹤0.01% 4467
2019
Q3 		$1.48M Sell
10,400
-13,000
-56% -$1.79M ﹤0.01% 4852
2019
Q2 		$2.93M Buy
23,400
+11,200
+92% +$1.32M ﹤0.01% 3488
2019
Q1 		$1.34M Sell
12,200
-4,400
-27% -$458K ﹤0.01% 4430
2018
Q4 		$1.63M Buy
16,600
+4,200
+34% +$456K ﹤0.01% 3834
2018
Q3 		$1.53M Sell
12,400
-700
-5% -$78.5K ﹤0.01% 4439
2018
Q2 		$1.3M Buy
+13,100
New +$1.21M ﹤0.01% 4809
2018
Q1 		– Sell
-11,700
Closed -$1.15M – 10294
2017
Q4 		$1.15M Buy
+11,700
New +$1.15M ﹤0.01% 4941
2017
Q3 		– Sell
-10,200
Closed -$964K – 9738
2017
Q2 		$964K Buy
+10,200
New +$938K ﹤0.01% 5343
2016
Q3 		– Sell
-11,000
Closed -$835K – 9143
2016
Q2 		$835K Buy
11,000
+8,100
+279% +$589K ﹤0.01% 5215
2016
Q1 		$201K Buy
+2,900
New +$174K ﹤0.01% 7964
2014
Q3 		– Sell
-6,400
Closed -$270K – 10009
2014
Q2 		$270K Buy
6,400
+300
+5% +$12.8K ﹤0.01% 8565
2014
Q1 		$269K Buy
+6,100
New +$287K ﹤0.01% 7759

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's WST Position: Q1 2026 in Review

Susquehanna International Group reduced its West Pharmaceutical (WST) stake by 55% in Q1 2026, selling an estimated $2.43M and leaving 7,926 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

Susquehanna International Group first reported a position in WST in Q2 2013 and has held it in 45 quarters since. The position peaked at $27.4M in Q3 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Susquehanna International Group held 7,926 shares of West Pharmaceutical worth $1.99M as of Q1 2026.
  • Susquehanna International Group sold 9,758 West Pharmaceutical shares in Q1 2026, an estimated $2.43M.
  • West Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6192 holding.
  • Susquehanna International Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's West Pharmaceutical position peaked at $27.4M in Q3 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.